Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

NCT04341870 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

SUSPENDED

Status

27

Enrollment

OTHER

Sponsor class

Stopped DSMB recommendation (futility)

Conditions

COVID19
SARS-CoV-2 Infection

Interventions

DRUG: Sarilumab
DRUG: Azithromycin
DRUG: Hydroxychloroquine

Sponsor

Assistance Publique - Hôpitaux de Paris